Literature DB >> 25454740

Brain metastasis and response to ado-trastuzumab emtansine: a case report and literature review.

Richa Kalsi1, Steven Feigenberg2, Young Kwok2, Katherine Tkaczuk1, Minesh Mehta2, Saranya Chumsri3.   

Abstract

Entities:  

Keywords:  Ado-trastuzumab emtansine; CNS metastasis; HER2; Lapatinib; Radiation

Mesh：

Substances：

Year:  2014        PMID： 25454740     DOI： 10.1016/j.clbc.2014.10.003

Source DB:  PubMed          Journal:  Clin Breast Cancer        ISSN： 1526-8209            Impact factor:   3.225


× No keyword cloud information.
  15 in total

Review 1.  Current chemotherapeutic regimens for brain metastases treatment.

Authors:  Joo Yeon Nam; Barbara J O'Brien
Journal:  Clin Exp Metastasis       Date:  2017-09-16       Impact factor: 5.150

2.  ATTAIN: Phase III study of etirinotecan pegol versus treatment of physician's choice in patients with metastatic breast cancer and brain metastases.

Authors:  Debu Tripathy; Sara M Tolaney; Andrew D Seidman; Carey K Anders; Nuhad Ibrahim; Hope S Rugo; Chris Twelves; Veronique Dieras; Volkmar Müller; Mary Tagliaferri; Alison L Hannah; Javier Cortés
Journal:  Future Oncol       Date:  2019-05-10       Impact factor: 3.404

3.  [Therapeutic options for brain metastases].

Authors:  M Preusser; F Winkler
Journal:  Nervenarzt       Date:  2015-06       Impact factor: 1.214

Review 4.  Investigational chemotherapy and novel pharmacokinetic mechanisms for the treatment of breast cancer brain metastases.

Authors:  Neal Shah; Afroz S Mohammad; Pushkar Saralkar; Samuel A Sprowls; Schuyler D Vickers; Devin John; Rachel M Tallman; Brandon P Lucke-Wold; Katherine E Jarrell; Mark Pinti; Richard L Nolan; Paul R Lockman
Journal:  Pharmacol Res       Date:  2018-03-28       Impact factor: 7.658

5.  ACTIVITY OF TRASTUZUMAB-EMTANSINE (TDM1) IN HER2-POSITIVE BREAST CANCER BRAIN METASTASES: A CASE SERIES.

Authors:  Kevin C Keith; Yueh Lee; Matthew G Ewend; Timothy M Zagar; Carey K Anders
Journal:  Cancer Treat Commun       Date:  2016

6.  LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases.

Authors:  Amanda E D Van Swearingen; Marni B Siegel; Allison M Deal; Maria J Sambade; Alan Hoyle; D Neil Hayes; Heejoon Jo; Paul Little; Elizabeth Claire Dees; Hyman Muss; Trevor Jolly; Timothy M Zagar; Nirali Patel; C Ryan Miller; Joel S Parker; J Keith Smith; Julie Fisher; Nikita Shah; Lisle Nabell; Rita Nanda; Patrick Dillon; Vandana Abramson; Lisa A Carey; Carey K Anders
Journal:  Breast Cancer Res Treat       Date:  2018-06-25       Impact factor: 4.872

Review 7.  Breast cancer brain metastases: biology and new clinical perspectives.

Authors:  Isabell Witzel; Leticia Oliveira-Ferrer; Klaus Pantel; Volkmar Müller; Harriet Wikman
Journal:  Breast Cancer Res       Date:  2016-01-19       Impact factor: 6.466

8.  Safety and efficacy of the combination of T-DM1 with radiotherapy of the central nervous system in a patient with HER2-positive metastatic breast cancer: case study and review of the literature.

Authors:  Giuliano Santos Borges; Rodrigo Kraft Rovere; Stéphanie Mereniuk Kappel Dias; Fernando Henrique Chong; Mayara Dos Santos Morais
Journal:  Ecancermedicalscience       Date:  2015-10-22

9.  Expansive hematoma in delayed cerebral radiation necrosis in patients treated with T-DM1: a report of two cases.

Authors:  Koichi Mitsuya; Junichiro Watanabe; Yoko Nakasu; Nakamasa Hayashi; Hideyuki Harada; Ichiro Ito
Journal:  BMC Cancer       Date:  2016-07-04       Impact factor: 4.430

10.  Efficacy of T-DM1 for leptomeningeal and brain metastases in a HER2 positive metastatic breast cancer patient: new directions for systemic therapy - a case report and literature review.

Authors:  Giuseppina Rosaria Rita Ricciardi; Alessandro Russo; Tindara Franchina; Silvia Schifano; Giampiero Mastroeni; Anna Santacaterina; Vincenzo Adamo
Journal:  BMC Cancer       Date:  2018-01-25       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.